ロイシン脱水素酵素、ロイシンデヒドロゲナーゼ
WordNet
- a white crystalline amino acid occurring in proteins that is essential for nutrition; obtained by the hydrolysis of most dietary proteins
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/11/19 04:18:41」(JST)
[Wiki en表示]
leucine dehydrogenase |
Identifiers |
EC number |
1.4.1.9 |
CAS number |
9082-71-7 |
Databases |
IntEnz |
IntEnz view |
BRENDA |
BRENDA entry |
ExPASy |
NiceZyme view |
KEGG |
KEGG entry |
MetaCyc |
metabolic pathway |
PRIAM |
profile |
PDB structures |
RCSB PDB PDBe PDBsum |
Gene Ontology |
AmiGO / EGO |
Search |
PMC |
articles |
PubMed |
articles |
NCBI |
proteins |
|
In enzymology, a leucine dehydrogenase (EC 1.4.1.9) is an enzyme that catalyzes the chemical reaction
- L-leucine + H2O + NAD+ 4-methyl-2-oxopentanoate + NH3 + NADH + H+
The 3 substrates of this enzyme are L-leucine, H2O, and NAD+, whereas its 4 products are 4-methyl-2-oxopentanoate, NH3, NADH, and H+.
This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-NH2 group of donors with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is L-leucine:NAD+ oxidoreductase (deaminating). Other names in common use include L-leucine dehydrogenase, L-leucine:NAD+ oxidoreductase, deaminating, and LeuDH. This enzyme participates in valine, leucine and isoleucine degradation and valine, leucine and isoleucine biosynthesis.
Structural studies[edit]
As of late 2007, only one structure has been solved for this class of enzymes, with the PDB accession code 1LEH.
References[edit]
- Sanwal BD and Zink MW (1961). "L-Leucine dehydrogenase of Bacillus cereus". Arch. Biochem. Biophys. 94: 430–435. doi:10.1016/0003-9861(61)90070-4.
- Zink MW and Sanwal BD (1962). "The distribution and substrate specificity of L-leucine dehydrogenase". Arch. Biochem. Biophys. 99: 72–77. doi:10.1016/0003-9861(62)90245-X.
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- A one-pot system for production of L-2-aminobutyric acid from L-threonine by L-threonine deaminase and a NADH-regeneration system based on L-leucine dehydrogenase and formate dehydrogenase.
- Tao R1, Jiang Y, Zhu F, Yang S.Author information 1Key Laboratory of Synthetic Biology, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, 200032, China, rstao@cibt.ac.cn.AbstractL-2-Aminobutyric acid (L-ABA) is an unnatural amino acid that is a key intermediate for the synthesis of several important drugs. It can be produced by transaminase or dehydrogenase from α-ketobutyric acid, which can be synthesized enzymatically from the bulk amino acid, L-threonine. Deamination of L-threonine followed by a hydrogenation reaction gave almost the theoretical yield and was estimated to be more cost-effective than the established chemical process. L-Threonine deaminase from Escherichia coli, L-leucine dehydrogenase from Bacillus cereus, and formate dehydrogenase from Pseudomonas sp. were over-expressed in E. coli and used for one-pot production of L-ABA with formate as a co-substrate for NADH regeneration. 30 mol L-threonine were converted to 29.2 mol L-ABA at 97.3 % of theoretical yield and with productivity of 6.37 g l(-1) h(-1) at 50 l. This process offers a promising approach to fulfil industrial requirements for L-ABA.
- Biotechnology letters.Biotechnol Lett.2014 Apr;36(4):835-41. doi: 10.1007/s10529-013-1424-y. Epub 2013 Dec 10.
- L-2-Aminobutyric acid (L-ABA) is an unnatural amino acid that is a key intermediate for the synthesis of several important drugs. It can be produced by transaminase or dehydrogenase from α-ketobutyric acid, which can be synthesized enzymatically from the bulk amino acid, L-threonine. Deamination of
- PMID 24322776
- Metabolism of activated T lymphocytes.
- Maciolek JA1, Alex Pasternak J1, Wilson HL2.Author information 1Vaccine and Infectious Disease Organization (VIDO)-Home of the International Vaccine Centre (InterVac), University of Saskatchewan, 120 Veterinary Road, Saskatoon, S7N 5E3, Canada.2Vaccine and Infectious Disease Organization (VIDO)-Home of the International Vaccine Centre (InterVac), University of Saskatchewan, 120 Veterinary Road, Saskatoon, S7N 5E3, Canada. Electronic address: heather.wilson@usask.ca.AbstractActivated T cells undergo metabolic reprogramming which promotes glycolytic flux and lactate production as well as elevated production of lipids, proteins, nucleic acids and other carbohydrates (i.e. induction of biomass) even in the presence of oxygen. Activated T cells show induced expression of, among other things, Glucose Transporter 1 and several glycolytic enzymes, including ADP-Dependent Glucokinase and the low affinity isoform Pyruvate Kinase-M2 (which promote glycolytic flux), as well Glutamine Transporters and Glycerol-3-phosphate Dehydrogenase 2 which make available glutamate and glycerol-3-phosphate as mitochondrial energy sources. Intracellular leucine concentrations critically regulate mammalian target of rapamycin (mTOR) signaling to promote Th1, Th2, and Th17 CD4+ T effector cell differentiation. In contrast, T regulatory (Treg) cells are generated when AMP-Activating Protein Kinase signaling is activated and mTOR activation is suppressed. Unlike effector CD4+ and CD8+ T cells, Tregs and memory T cells oxidize fatty acids for fuel. Effector and memory T cells perform different functions and thus show distinct metabolic profiles which are exquisitely controlled by cellular signaling. Upon activation, T cells express the insulin and leptin receptors on their surface and become sensitive to insulin signaling and nutrient availability and show changes in differentiation. Thus, metabolism and nutrient availability influence T cell activation and function.
- Current opinion in immunology.Curr Opin Immunol.2014 Apr;27C:60-74. doi: 10.1016/j.coi.2014.01.006. Epub 2014 Feb 18.
- Activated T cells undergo metabolic reprogramming which promotes glycolytic flux and lactate production as well as elevated production of lipids, proteins, nucleic acids and other carbohydrates (i.e. induction of biomass) even in the presence of oxygen. Activated T cells show induced expression of,
- PMID 24556090
- Branched-chain amino acid metabolism: from rare Mendelian diseases to more common disorders.
- Burrage LC1, Nagamani SC, Campeau PM, Lee BH.Author information 1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.AbstractBranched-chain amino acid (BCAA) metabolism plays a central role in the pathophysiology of both rare inborn errors of metabolism and the more common multifactorial diseases. Although deficiency of the branched-chain ketoacid dehydrogenase (BCKDC) and associated elevations in the BCAAs and their ketoacids have been recognized as the cause of maple syrup urine disease (MSUD) for decades, treatment options for this disorder have been limited to dietary interventions. In recent years, the discovery of improved leucine tolerance after liver transplantation has resulted in a new therapeutic strategy for this disorder. Likewise, targeting the regulation of the BCKDC activity may be an alternative potential treatment strategy for MSUD. The regulation of the BCKDC by the branched-chain ketoacid dehydrogenase kinase has also been implicated in a new inborn error of metabolism characterized by autism, intellectual disability and seizures. Finally, there is a growing body of literature implicating BCAA metabolism in more common disorders such as the metabolic syndrome, cancer and hepatic disease. This review surveys the knowledge acquired on the topic over the past 50 years and focuses on recent developments in the field of BCAA metabolism.
- Human molecular genetics.Hum Mol Genet.2014 Apr 1. [Epub ahead of print]
- Branched-chain amino acid (BCAA) metabolism plays a central role in the pathophysiology of both rare inborn errors of metabolism and the more common multifactorial diseases. Although deficiency of the branched-chain ketoacid dehydrogenase (BCKDC) and associated elevations in the BCAAs and their keto
- PMID 24651065
Japanese Journal
- Phenotypic Variability and Newly Identified Mutations of the IVD Gene in Japanese Patients with Isovaleric Acidemia
- Sakamoto Osamu,Arai-Ichinoi Natsuko,Mitsubuchi Hiroshi,Chinen Yasutsugu,Haruna Hidenori,Maruyama Hidehiko,Sugawara Hidenori,Kure Shigeo
- The Tohoku Journal of Experimental Medicine 236(2), 103-106, 2015
- … Isovaleric acidemia (IVA) is an autosomal recessive inborn error affecting leucine metabolism. … It is caused by a deficiency in isovaleryl-CoA dehydrogenase (IVD), a mitochondrial matrix enzyme that catalyzes the oxidation of isovaleryl-CoA to 3-methylcrotonyl-CoA. …
- NAID 130005072136
- 好塩性アーキアの膜脂質イソプレノイド生成機構-ロイシン-メバロン酸経路と関連酵素の存在
- 山内 敬明,田上 諒
- 日本地球化学会年会要旨集 60(0), 139, 2013
- 好塩性古細菌の特徴的なイソプレノイド脂質コア部分の生合成機構の詳細について,ロイシンからメバロン酸への短絡経路と関連酵素の存在を指摘するため,立体特異的重水素化標識ロイシンを用いて検討した。(3S)- および(3R)-[3-d]ロイシンを調製し,その取り込み実験より,プロキラル水素が立体特異的に変換されていることが示され,これは相当するイソバレリル-CoA 脱水素酵素が基質を立体特異的に認識してい …
- NAID 130004593890
- 超好熱アーキアの新規なNAD(P)依存性アミノ酸脱水素酵素の機能と構造解析
- 米田 一成
- ビタミン 86(2), 74-83, 2012-02-25
- … In contrast to abundant information available about glutamate, alanine, leucine and phenylalanine dehydrogenases, information about the structure and function of lysine, aspartate, threonine dehydrogenases has been rather limited so far. …
- NAID 110009419212
Related Links
- leu·cine de·hy·dro·gen·ase an enzyme that catalyzes the reaction of l-leucine, water, and NAD + to produce NADH, ammonia, and 4-methyl-2-oxopentanoate; used ... Disclaimer All content on this website, including dictionary ...
- Information on EC 1.4.1.9 - leucine dehydrogenase BRENDA home login history all enzymes BRENDA home History Enzyme Nomenclature EC number Recommended Name Reaction Reaction Type Pathway Systematic Name ...
★リンクテーブル★
[★]
- 英
- leucine dehydrogenase
- 関
- ロイシンデヒドロゲナーゼ
[★]
- 英
- leucine dehydrogenase
- 関
- ロイシン脱水素酵素
[★]
脱水素酵素 デヒドロゲナーゼ
[★]
脱水素酵素 デヒドロゲナーゼ